Pharmacology of carbon nanotubes: Toxicokinetics,excretion and tissue accumulation |
| |
| Authors: | Hanene Ali-Boucetta Kostas Kostarelos |
| |
| Institution: | 1. Pharmacy, Pharmacology and Therapeutics, School of Clinical and Experimental Medicine, Medical School, University of Birmingham, Birmingham B15 2TT, UK;2. Nanomedicine Lab, Faculty of Medical & Human Sciences and National Graphene Institute, University of Manchester, AV Hill Building, Manchester M13 9PT, UK |
| |
| Abstract: | Carbon nanotubes (CNT) are increasingly being investigated for their use in biomedical applications and nanomedicine. An emergent need for the understanding of their in vivo biodistribution and pharmacokinetics is therefore needed to establish the essential properties and criteria for their further development as targeted CNT delivery systems to specific tissues for diagnostics and therapeutic purposes. Until their biodistribution and toxicoketic profiles are fully understood, their translation into the clinic will be hindered. This review will highlight the important factors affecting the biodistribution and pharmacokinetic profile of CNT and address their toxicokinetics following systemic, pulmonary and dermal exposure. |
| |
| Keywords: | Carbon nanotubes CNT Biodistribution Toxicokinetics Functionalisation Nanotoxicology |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
